Context Therapeutics
(NASDAQ) CNTX
Context Therapeutics Financials at a Glance
Market Cap
$264.61M
Revenue (TTM)
$0.00
Net Income (TTM)
$26.44M
EPS (TTM)
$-0.28
P/E Ratio
-10.29
Dividend
$0.00
Beta (Volatility)
0.94 (Low)
Dividend
$0.00
Beta (Volatility)
0.94 (Low)
Price
$2.90
Volume
18,481
Open
$2.95
Price
$2.90
Volume
18,481
Open
$2.95
Previous Close
$2.90
Daily Range
$2.80 - $2.95
52-Week Range
$0.49 - $3.62
Dividend
$0.00
Beta (Volatility)
0.94 (Low)
Price
$2.90
Volume
18,481
Open
$2.95
Previous Close
$2.90
Daily Range
$2.80 - $2.95
52-Week Range
$0.49 - $3.62
CNTX News
CNTX: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Context Therapeutics
Industry
Pharmaceuticals
Sector
Health CareEmployees
12
CEO
Martin A. Lehr, MA
Website
www.contexttherapeutics.comHeadquarters
Philadelphia, PA 19103, US
CNTX Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-34%
Return on Capital
-41%
Return on Assets
-33%
Earnings Yield
-9.72%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$264.61M
Shares Outstanding
91.88M
Volume
18.48K
Short Interest
0.00%
Avg. Volume
1.58M
Financials (TTM)
Gross Profit
$0.00
Operating Income
$29.92M
EBITDA
$29.91M
Operating Cash Flow
$14.56M
Capital Expenditure
$14.76M
Free Cash Flow
$29.31M
Cash & ST Invst.
$94.43M
Total Debt
$219.38K
Context Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$4.07K
N/A
Gross Margin
0.00%
N/A
Market Cap
$264.61M
N/A
Market Cap/Employee
$22.05M
N/A
Employees
12
N/A
Net Income
$9.69M
+44.5%
EBITDA
$9.69M
+48.2%
Quarterly Fundamentals
Net Cash
$76.80M
-9.2%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$21.22K
-84.9%
Short Term Debt
$118.98K
+14.2%
Return on Assets
-33.37%
N/A
Return on Invested Capital
-41.27%
N/A
Free Cash Flow
$6.58M
-239.0%
Operating Cash Flow
$6.58M
-240.3%